Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth

Pediatric Diabetes

Volumn 8, Issue SUPPL. 9, 2007, Pages 70-75

  Weiss, Ram ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Impaired glucose tolerance; Insulin resistance; Obesity

Indexed keywords

GLUCOSE; LIPID;

CHILD; DIET RESTRICTION; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ETHNIC GROUP; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; JUVENILE DIABETES MELLITUS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WEIGHT GAIN;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; OBESITY; PREDIABETIC STATE; RISK FACTORS; UNITED STATES;

EID: 35948979266     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00336.x     Document Type: Review

References (34)

1. Keamseng C, Likitmaksul S, Kiattisakthavee P et al. Risk of Metabolic Disturbance and Diabetes Development in Thai Obese Children. 29th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes, Saint-Malo, France, September 3-6, 2003.
2. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004: 89: 108-113.
3. Tounian P, Aggoun Y, Dubern B et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: A prospective study. Lancet 2001: 358: 1400-1404.
4. Invitti C, Gilardini L, Pontiggia B, Morabito F, Mazzilli G, Viberti G. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy. Nutr Metab Cardiovasc Dis 2006: 16: 256-262.
5. Wiegand S, Dannemann A, Krude H, Gruters A. Impaired glucose tolerance and type 2 diabetes mellitus: A new field for pediatrics in Europe. Int J Obes (Lond) 2005: 29 (Suppl. 2): S136-S142.
6. Williams DE, Cadwell BL, Cheng YJ et al. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics 2005: 116: 1122-1126.
7. Duncan GE. Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002. Arch Pediatr Adolesc Med 2006: 160: 523-528.
8. Baranowski T, Cooper DM, Harrell J et al. The STOPP-T2D Prevention Study Group. Presence of diabetes risk factors in a large U.S. eighth-grade cohort. Diabetes Care 2006: 29: 212-217.
9. Valerio G, Licenziati MR, Iannuzzi A et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006: 16: 279-284.
10. Yamamoto-Kimura L, Posadas-Romero C, Posadas-Sanchez R, Zamora-Gonzalez J, Cardoso-Saldana G, Mendez Ramirez I. Prevalence and interrelations of cardiovascular risk factors in urban and rural Mexican adolescents. J Adolesc Health 2006: 38: 591-598.
11. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003: 46: 3-19.
12. Bergman RN, Finegood DT, Kahn SE. The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 2002: 32 (Suppl. 3): 35-45.
13. Goldstein BJ. Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 2002: 90: 3G-10G.
14. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999: 104: 787-794.
15. Gerich JE. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 2003: 78: 447-456.
16. Sinha R, Fisch G, Teague B et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002: 346: 802-810.
17. Weiss R, Dufour S, Taksali SE et al. Prediabetes in obese youth: A syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003: 362: 951-957.
18. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000: 106: 171-176.
19. Bjorntorp P, Rosmond R. Visceral obesity and diabetes. Drugs 1999: 58 (Suppl. 1): 13-18.
20. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, Bonadonna R. Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 2005: 54: 1735-1743.
21. Dabelea D, Pettitt DJ, Jones KL, Arslanian SA. Type 2 diabetes mellitus in minority children and adolescents. An emerging problem. Endocrinol Metab Clin North Am 1999: 28: 709-729.
22. Arslanian SA. Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002: 15 (Suppl. 1): 509-517.
23. Weiss R, Dziura JD, Burgert TS, Taksali SE, Tamborlane WV, Caprio S. Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents. Diabetologia 2006: 49: 571-579.
24. Rosenbaum M, Nonas C, Horlick M et al. El Camino Diabetes Prevention Group. Beta-cell function and insulin sensitivity in early adolescence: association with body fatness and family history of type 2 diabetes mellitus. J Clin Endocrinol Metab 2004: 89: 5469-5476.
25. Edelstein SL, Knowler WC, Bain RP et al. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies. Diabetes 1997: 46: 701-710.
26. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 1988: 319: 1500-1506.
27. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005: 28: 902-909.
28. Knowler WC, Barrett-Connor E, Fowler SE et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002: 346: 393-403.
29. Weiss R et al. Degree of obesity and glucose allostasis are major effectors of glucose tolerance dynamics in obese youth. Diabetes Care 2007: 30: 1845-1850.
30. Stumvoll M, Tataranni PA, Stefan N, Vozarova B, Bogardus C. Glucose allostasis. Diabetes 2003: 52: 903-909.
31. Dankner R, Abdul-Ghani MA, Gerber Y, Chetrit A, Wainstein J, Raz I. Predicting the 20-year diabetes incidence rate. Diabetes Metab Res Rev 2007: 23: 551-558.
32. Tirosh A, Shai I, Tekes-Manova D et al. Israeli Diabetes Research Group. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005: 353: 1454-1462.
33. Weiss R, Dziura J, Burgert TS et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004: 350: 2362-2374.
34. Freedman DS, Mei Z, Srinivasan SR, Berenson GS, Dietz WH. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: The Bogalusa Heart Study. J Pediatr 2007: 150: 12-17.